Intervention

Telmisartan

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 74 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials74

Recruiting2

Common conditions25

Lead sponsors shown15

Clinical trials

60 shown

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialNCT07207057 · 2025-09-12

Telmisartan in Prostate CancerNCT06168487 · 2024-04-22

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNCT07370506 · 2026-02-01

NOT_YET_RECRUITING

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic SyndromeNCT05843162 · 2023-06-01

Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney FunctionsNCT04736329 · 2021-02-01

Determining the Optimal Dose of AD-209 in Patients With Essential HypertensionNCT04218552 · 2020-02-25

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineNCT04158076 · 2020-01-23

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and TelmisartanNCT03872232 · 2019-02-26

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)NCT03504566 · 2017-11-15

Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims DataNCT04354376 · 2017-09-22

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims DataNCT04354350 · 2017-09-22

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With HypertensionNCT03267329 · 2017-09-11

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaNCT03566316 · 2015-11-24

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersNCT02933658 · 2015-11-01

CKD-828 (80/5mg) Pharmacokinetic StudyNCT02358824 · 2015-02-01

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionNCT02170246 · 2015-01-28

Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake PopulationNCT02255253 · 2014-10-01

INTERVENCION TrialNCT02373163 · 2014-09-01

CKD-828 (80/5mg) Pharmacokinetic StudyNCT02250833 · 2014-09-01

A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RNCT02079805 · 2014-06-01

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)NCT02152969 · 2014-05-01

To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male VolunteersNCT02579356 · 2014-05-01

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsNCT02085265 · 2014-03-01

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)NCT01928927 · 2014-01-01

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and HyperlipidemiaNCT01914432 · 2013-11-01

Non-invasive Haemodynamic Assessment in HypertensionNCT01996085 · 2013-01-01

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart DiseaseNCT01578772 · 2012-08-01

HIGH Altitude CArdiovascular REsearch in the ANDESNCT01830530 · 2012-05-01

Twynsta Study With Lifestyle Modifications in Korean Patients With HypertensionNCT01316419 · 2011-03-01

Telmisartan 80mg Non-responder TrialNCT01222520 · 2010-10-01

Telmisartan, Amlodipine and Flow Mediated DilationNCT01180205 · 2010-08-01

CKD-828 Primary Hypertension Trial(Dose-selection)NCT01128322 · 2010-07-01

HIV and Fat AccumulationNCT01088295 · 2010-05-01

Antihypertensive Medications and the Risk of SepsisNCT02248896 · 2010-01-01

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionNCT00926289 · 2009-06-01

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment WithdrawalNCT00865020 · 2009-03-01

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With SchizophreniaNCT00981526 · 2009-03-01

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsNCT00538486 · 2008-02-01

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood VesselsNCT00559286 · 2007-12-01

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.NCT00750113 · 2007-10-01

Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AFNCT01435161 · 2007-05-01

Treatment of Insulin Resistance in Hypertensive, Obese AdolescentsNCT00185705 · 2006-10-01

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With HypertensionNCT02242344 · 2006-04-01

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term ObservationNCT00659581 · 2006-04-01

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionNCT00281593 · 2006-04-01

TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or OlderNCT02242877 · 2006-02-01

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese PatientsNCT00288717 · 2006-02-01

HALT Progression of Polycystic Kidney Disease Study ANCT00283686 · 2006-01-01

HALT Progression of Polycystic Kidney Disease Study BNCT01885559 · 2006-01-01

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionNCT00257491 · 2005-11-01

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)NCT02242396 · 2005-08-01

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgNCT00146341 · 2005-04-01

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With HypertensionNCT02242383 · 2005-01-01

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and PatientsNCT02242851 · 2004-09-01

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionNCT00153049 · 2004-06-01

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With HypertensionNCT02242838 · 2003-09-01

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate HypertensionNCT02242812 · 2003-09-01

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt NephropathyNCT00153023 · 2003-04-01

Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 DiabetesNCT00240422 · 2003-02-01

PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNNCT00274599 · 2002-10-09

Common conditions

Leading sponsors

Boehringer Ingelheim 33 Chong Kun Dang Pharmaceutical 4 Addpharma Inc. 3 Yuhan Corporation 3 Brigham and Women's Hospital 2 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 University of California, Los Angeles 2 Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1 Bayer 1 Cairo University 1 Daewon Pharmaceutical Co., Ltd. 1 IlDong Pharmaceutical Co Ltd 1 Istituto Auxologico Italiano 1 Johannes Gutenberg University Mainz 1 Military Institute od Medicine National Research Institute 1

Trial status mix

COMPLETED63

TERMINATED4

UNKNOWN3

RECRUITING2

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

PHASE422

PHASE318

PHASE29

PHASE18

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.